Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain

Autor: Ribera JM, García O, Buendía-Ureña B, Terol MJ, Vicent A, Vall-Llovera F, Bergua J, García-Cadenas I, Esteve J, Ribera J, Acuña-Cruz E, Herrera P, Hernández-Rivas JM, Abrisqueta P, González-Campos J, Rodríguez C, Bastos-Oreiro M, Genescà E, Caminos N, Queipo de Llano MP, Cladera A, Sancho JM, Members of PETHEMA: Josep-Maria Riberaa, Olga Garcíaa, Ferran Vall-Lloverae, Jua

Publikováno v: Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b9a1fdc3971f354a7ba22d7e64d8f523
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15649

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

Autor: Camino Estivill, Anna Aventin, J. Bargay, Josep M Marti-Tutusaus, Jordi Esteve, Mar Tormo, Andreu Llorente, Inmaculada Heras, Josep-Maria Ribera, Montserrat Hoyos, de Llano Mp, Maite Carricondo, Josep F. Nomdedeu, David Gallardo, Elena Bussaglia, Antoni Garcia, Salut Brunet, Olga Salamero, Rafael F. Duarte, Jordi Sierra

Publikováno v: Leukemia. 27(11)

We retrospectively assessed whether normalized bone marrow WT1 levels could be used for risk stratification in a consecutive series of 584 acute myeloid leukemia (AML) patients. A cutoff value of 5065 copies at diagnosis identified two prognostic gro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b7640728920181a2a39eab2788ac164
https://pubmed.ncbi.nlm.nih.gov/23584566

A586 A Slow Pattern of Response in a Relapsed Multiple Myeloma Patient Treated with Lenalidomide

Autor: Ramirez, G, de Llano, MP, Campos, A, Rosell, A, Garcia, R, del Castillo, S

Publikováno v: In Clinical Lymphoma & Myeloma February 2009 9 Supplement 1:S88-S89

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Autor: Díaz-Beyá, Marina, Brunet Mauri, Maria Salut, Nomdedeu, Josep, Pratcorona, Marta, Cordeiro, Anna, Gallardo, David, Escoda, Lourdes, Tormo, Mar, Heras, Inmaculada, Ribera, Jose-Maria, Duarte, Rafael, Llano Queipo, María Paz de, Bargay, Joan, Sampol, Antonia, Nomdedeu, Meritxell, Risueño, Ruth M., Hoyos Colell, Montserrat, Sierra Gil, Jorge, Monzo, Mariano, Navarro, Alfons, Esteve Reyner, Jordi, Cooperative AML group CETLAM, Universitat Autònoma de Barcelona

Publikováno v: Oncotarget
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Europe PubMed Central
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Long non-coding RNAs (lncRNAs) are deregulated in several tumors, although their role in acute myeloid leukemia (AML) is mostly unknown. We have examined the expression of the lncRNA HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) in 241 AML patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363669f60cd22dc578629ec6036d0e3e
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945568293&doi=10.18632/oncotarget.5148&partnerID=40&md5=52230923b31c155eb0df41820cea86be

Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.

Autor: Ribera JM; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Morgades M; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Genescà E; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Chapchap EC; Hematology Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Montesinos P; Hematology Department, Hospital Universitari i Politènic La Fe, Valencia, Spain., Acuña-Cruz E; Hematology Department, Hospital Universitari i Politènic La Fe, Valencia, Spain., Gil C; Hematology Department, Hospital General de Alicante, Alicante, Spain., García-Cadenas I; Hematology Department, Hospital de Sant Pau, Barcelona, Spain., Barba P; Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., González-Campos J; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Queipo de Llano MP; Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Torrent A; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Ribera J; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Granada I; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Bernal T; Hematology Department, Hospital Central de Asturias, ISPA, IUOPA, Oviedo, Spain., Díaz-Beyá M; Hematology Department, Hospital Clínic, Barcelona, Spain., Amigo ML; Hematology Department, Hospital Morales Meseguer, Murcia, Spain., Coll R; Hematology Department, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain., Tormo M; Hematology and Oncology Department, Instituto de investigación INCLIVA, Hospital Clínico Universitario, Valencia, Spain., Vall-Llovera F; Hematology Department, Hospital Universitari Mútua de Terrasa, Terrassa, Spain., Gómez-Centurión I; Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Sánchez-Sánchez MJ; Hematology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Soria B; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Cladera A; Hematology Department, Hospital Son Llàtzer, Palma de Mallorca, Spain., Artola MT; Hematology Department, Hospital Universitario de Donostia, Donostia, Spain., Garcia-Guiñon A; Hematology Department, Hospital Arnau de Vilanova, Lleida, Spain., Giménez-Conca A; Hematology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Amador ML; Hematology Department, Complejo Hospitalario de Pontevedra, Spain., Martínez-Sánchez P; Hematology Department, Hospital 12 de Octubre, Madrid, Spain., Algarra JL; Hematology Department, Hospital General Universitario Albacete, Albacete, Spain., Vidal MJ; Hematology Department, Hospital Universitario de León, León, Spain., Alonso N; Hematology Department, Hospital Universitario Santiago de Compostela, Santiago, Spain., Maluquer C; Hematology Department, Institut Catala d'Oncologia-Hospital Duran y Reynals, L'Hospitalet de Llobregat, Barcelona, Spain., Llorente L; Hematology Department, Hospital HM Sanchinarro, Madrid, Spain., García-Boyero R; Hematology Department, Hospital General Universitario de Castellón, Castellón, Spain., Ciudad J; Hematology Department, Centro de Investigación del Cáncer, IBSAL, IBMCC, CIBERONC, Hospital Universitario, Universidad de Salamanca-CSIC, Salamanca, Spain., Feliu E; Hematology Department, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Orfao A; Hematology Department, Centro de Investigación del Cáncer, IBSAL, IBMCC, CIBERONC, Hospital Universitario, Universidad de Salamanca-CSIC, Salamanca, Spain.

Publikováno v: Hematological oncology [Hematol Oncol] 2021 Oct; Vol. 39 (4), pp. 529-538. Date of Electronic Publication: 2021 Aug 18.